Spontaneous propeptide processing of mini-stromelysin-1 mutants blocked by APMA ((4-aminophenyl)mercuric acetate)

Grazyna Galazka, L. Jack Windsor, Henning Birkedal-Hansen, Jeffrey A. Engler

Research output: Contribution to journalArticle

6 Scopus citations


Human stromelysin-1 (SL-1) is a member of the stromelysin subfamily of matrix metalloproteinases (MMPs). The MMPs play a major role in the degradation of the extracellular matrix (ECM) during normal and pathological conditions. SL-1 like the other MMPs can be activated in vitro by the stepwise removal of the propeptide that contains a single unpaired cysteine which coordinates the active site zinc. Other residues in the propeptide also play a role in maintaining the latency of the enzymes. Deletion mutants and single-site amino acid replacements within the propeptide of a carboxyl- terminally truncated stromelysin-1 (mini-SL-1) were constructed and expressed in Escherichia coli to further examine what amino acids within the propeptide of SL-1 are important for maintaining latency. While the natural enzyme displayed some limited tendency to spontaneously (autolytically) convert to lower M(r) in a stepwise manner and finally to the fully processed form, all of the truncation mutants of more than 19 amino acids generated in E. coli showed greatly accelerated self-cleavage indicative of diminished stability and/or resistance to proteolysis of the residual propeptide. Mutant Δ63 as well as other mutants in which most of the propeptide had been deleted no longer responded to exposure to the organomercurial APMA by accelerated autolytic processing. Rather, APMA inhibited the autolytic processing in these mutants, further confirming the complexity of the action of this organomercurial in the activation of pro-MMPs.

Original languageEnglish (US)
Pages (from-to)1316-1322
Number of pages7
Issue number4
StatePublished - Jan 26 1999
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry

Fingerprint Dive into the research topics of 'Spontaneous propeptide processing of mini-stromelysin-1 mutants blocked by APMA ((4-aminophenyl)mercuric acetate)'. Together they form a unique fingerprint.

  • Cite this